Protalix BioTherapeutics, Inc. (PLX)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, Protalix BioTherapeutics, Inc. reported revenue of $52.74M, down 1.2% from the prior year. The company ran a net loss, with a net margin of -12.5%. It held $82.35M in total assets against $34.12M in total liabilities.
Key ratios (FY2025)
-10.4%
Operating margin
-12.5%
Net margin
-13.7%
Return on equity
-1.2%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $52.74M | $53.40M | $65.49M | $47.64M | $38.35M | $62.90M | $54.69M | $34.24M | $21.08M | $9.20M |
| Cost of Revenue | $26.99M | $24.32M | $22.98M | $19.59M | $16.35M | $10.87M | $10.89M | $9.30M | $15.23M | $8.40M |
| Gross Profit | — | — | — | — | — | — | — | — | $4.01M | $801.0K |
| Operating Income | -$5.50M | $3.92M | $10.46M | -$13.01M | -$20.46M | $2.71M | -$10.72M | -$19.31M | -$34.52M | -$33.16M |
| Net Income | -$6.60M | $2.93M | $8.31M | -$14.93M | -$27.58M | -$6.52M | -$18.28M | -$26.46M | -$83.44M | -$29.36M |
| EPS (Diluted) | $-0.08 | $0.04 | $0.09 | $-0.31 | $-0.62 | $-0.22 | $-1.23 | — | — | — |
| Total Assets | $82.35M | $73.42M | $84.43M | $55.79M | $73.67M | $67.93M | $45.39M | $61.13M | $72.21M | $82.25M |
| Total Liabilities | $34.12M | $30.21M | $50.87M | $66.43M | $79.70M | $94.97M | $115.71M | $114.01M | $101.67M | $92.20M |
| Shareholders' Equity | $48.23M | $43.21M | $33.57M | -$10.64M | -$6.04M | -$27.04M | -$70.32M | -$52.88M | -$29.46M | -$9.96M |
| Cash & Equivalents | $14.68M | $19.76M | $23.63M | $17.11M | $38.98M | $18.27M | $17.79M | $37.81M | $51.16M | $63.28M |
| Operating Cash Flow | -$11.99M | $8.67M | -$1.32M | -$25.00M | -$10.29M | -$26.11M | -$19.36M | -$7.74M | -$9.99M | -$32.10M |
| Capital Expenditures | $1.64M | $1.28M | $1.15M | $628.0K | $1.46M | $655.0K | $627.0K | $686.0K | $971.0K | $849.0K |
| Shares Outstanding | 80.43M | 75.85M | 72.95M | 53.79M | 45.56M | 34.77M | 14.84M | 14.84M | 143.73M | 124.13M |